TGFBR2 and cancer: Our study found for the first time that HTR1A simultaneously inhibits the TGF‐β/TβRII/Smad canonical signaling pathway and TGF‐β/TβRII/MEK/ERK/c‐Myc noncanonical signaling pathway, which play significant roles in cancer development.